ATE530563T1 - Rekombinante proteine einer pakistanischen hepatitis e variante und ihre verwendung in diagnoseverfahren und impfungen - Google Patents

Rekombinante proteine einer pakistanischen hepatitis e variante und ihre verwendung in diagnoseverfahren und impfungen

Info

Publication number
ATE530563T1
ATE530563T1 AT08004467T AT08004467T ATE530563T1 AT E530563 T1 ATE530563 T1 AT E530563T1 AT 08004467 T AT08004467 T AT 08004467T AT 08004467 T AT08004467 T AT 08004467T AT E530563 T1 ATE530563 T1 AT E530563T1
Authority
AT
Austria
Prior art keywords
hepatitis
pakistan
vaccinations
variant
recombinant proteins
Prior art date
Application number
AT08004467T
Other languages
English (en)
Inventor
Suzanne U Emerson
Robert H Purcell
Sergei A Tsarev
Robin A Robinson
Original Assignee
Us Gov Health & Human Serv
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv, Novavax Inc filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE530563T1 publication Critical patent/ATE530563T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT08004467T 1997-04-11 1998-04-09 Rekombinante proteine einer pakistanischen hepatitis e variante und ihre verwendung in diagnoseverfahren und impfungen ATE530563T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/840,316 US6054567A (en) 1997-04-11 1997-04-11 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

Publications (1)

Publication Number Publication Date
ATE530563T1 true ATE530563T1 (de) 2011-11-15

Family

ID=25282015

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98919756T ATE389021T1 (de) 1997-04-11 1998-04-09 Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff
AT08004467T ATE530563T1 (de) 1997-04-11 1998-04-09 Rekombinante proteine einer pakistanischen hepatitis e variante und ihre verwendung in diagnoseverfahren und impfungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT98919756T ATE389021T1 (de) 1997-04-11 1998-04-09 Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff

Country Status (10)

Country Link
US (1) US6054567A (de)
EP (2) EP1958958B1 (de)
JP (1) JP4390293B2 (de)
CN (1) CN1202252C (de)
AT (2) ATE389021T1 (de)
AU (1) AU739915B2 (de)
CA (1) CA2286399C (de)
DE (1) DE69839242T2 (de)
ES (1) ES2301195T3 (de)
WO (1) WO1998046761A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1345775A (zh) * 2000-09-30 2002-04-24 养生堂有限公司 用于预防、诊断及治疗戊型肝炎病毒的多肽,及它们作为诊断试剂和疫苗
US7005130B2 (en) * 2001-01-05 2006-02-28 Virginia Tech Intellectual Properties, Inc. Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
US20040234542A1 (en) * 2001-05-07 2004-11-25 Xiang-Jin Meng Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
WO2003068788A1 (en) * 2002-02-13 2003-08-21 Medimolecular Pty. Ltd. Method of isolating nucleic acids from stool samples
US20090305294A1 (en) * 2003-02-13 2009-12-10 Medimolecular Pty Ltd Method of isolating nucleic acids from stool samples
US10053742B2 (en) 2013-08-14 2018-08-21 Gen-Probe Incorporated Compositions and methods for detecting HEV nucleic acid
JP7777906B2 (ja) * 2022-03-01 2025-12-01 関西ペイント株式会社 木材用水性塗料組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5885768A (en) * 1988-06-17 1999-03-23 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis E virus peptide antigen and antibodies
US5686239A (en) * 1988-06-17 1997-11-11 Genelabs Technologies, Inc. Hepatitis E virus peptides and methods
US6214970B1 (en) * 1988-06-17 2001-04-10 Genelabs Technologies, Inc. Hepatitis E virus antigens and uses therefor
US6455492B1 (en) * 1988-06-17 2002-09-24 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
US5741490A (en) * 1988-06-17 1998-04-21 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
EP0440663A1 (de) 1988-08-08 1991-08-14 IFFIU, Michael A. Klappbares sesselrad mit stromlinienförmiger, in drei geteilter und faltbarer verkleidung
CA2016841C (en) 1989-05-16 1999-09-21 William D. Huse A method for producing polymers having a preselected activity
DE69133599D1 (de) * 1990-04-05 2008-08-21 Genelabs Tech Inc Enterisch übertragendes non-a/non-b-hepatitis-virus agens und charakteristische epitope von selbigem
DE69334299D1 (de) * 1992-09-18 2009-12-31 Us Gov Health & Human Serv Rekombinante proteine eines pakistani stammes von hepatitis e-virus sowie ihre verwendung in diagnostischen verfahren und als vakzine
CA2170521A1 (en) * 1993-09-24 1995-03-30 David Andrew Anderson Immunoreactive antigens of hepatitis e virus
EP0736087A1 (de) * 1993-12-22 1996-10-09 Abbott Laboratories Monoklonale antikoerper gegen hev orf-2 und verfahren zur deren verwendung
CN1148450C (zh) * 1994-10-03 2004-05-05 美国健康及大众服务部部长 戊型肝炎巴基斯坦病毒株的重组蛋白及其在诊断方法和疫苗中的用途

Also Published As

Publication number Publication date
EP1958958A1 (de) 2008-08-20
JP4390293B2 (ja) 2009-12-24
ES2301195T3 (es) 2008-06-16
CA2286399A1 (en) 1998-10-22
EP0972048B1 (de) 2008-03-12
JP2001524821A (ja) 2001-12-04
DE69839242T2 (de) 2009-03-12
US6054567A (en) 2000-04-25
AU7247098A (en) 1998-11-11
WO1998046761A1 (en) 1998-10-22
ATE389021T1 (de) 2008-03-15
CN1202252C (zh) 2005-05-18
AU739915B2 (en) 2001-10-25
CN1260000A (zh) 2000-07-12
EP1958958B1 (de) 2011-10-26
EP0972048A1 (de) 2000-01-19
CA2286399C (en) 2009-06-30
DE69839242D1 (de) 2008-04-24

Similar Documents

Publication Publication Date Title
LU91396I2 (fr) "La combinaison de la protéine L1 recombinante du papillomavirus humain de types 6,11,16 et 18" -Gardasil/Silgard
ATE229978T1 (de) Helicobacter proteine und impstoffe
ATE257015T1 (de) Rekombinante pockenviren des waschbaers sowie ihre verwendung als ein effektiver impfstoff gegen eine infektion mit immunschwaecheviren der katze
ATE245164T1 (de) Rekombinanter papillomavirus l1
DE69334299D1 (de) Rekombinante proteine eines pakistani stammes von hepatitis e-virus sowie ihre verwendung in diagnostischen verfahren und als vakzine
ATE183241T1 (de) Impstoff gegen streptococcus suis-infektion
ATE530563T1 (de) Rekombinante proteine einer pakistanischen hepatitis e variante und ihre verwendung in diagnoseverfahren und impfungen
LU91458I2 (fr) "Virus atténué des oreillons,souche RIT4385 (JL-1); virus atténué de la rougeole ; virus atténué de la rubéole ; et virus atténué de la varicelle."
PT1035133E (pt) Proteinas de fusao compreendendo veiculos que podem induzir uma dupla resposta imune
NO971529D0 (no) Rekombinante proteiner av en Pakistani stamme av hepatitt E og deres anvendelse i diagnostiske metoder og vaksiner

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties